|View printer-friendly version|
|August 01, 2000 3:29 p.m.|
|Teva to Receive 180 Days Market Exclusivity for Etodolac ER 500 & 600mg and will Ship Immediately|
Tentative approval for Etodolac ER 400mg
Jerusalem, Israel, August 1, 2000 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that it has received from the U.S. FDA final approval to manufacture and market Etodolac ER 500 and 600mg Tablets.